GlassScriptPhysician profile
Robert G Brame
NPI 1851318661
$240.52
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $65.87 · 2022: $44.12 · 2023: $108 · 2024: $22.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $131.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $130.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $39.97 | 2023-2024 | Alphagan P, Vuity, Lumigan |
| Oyster Point Pharma, INC. | $33.49 | 2023 | Tyrvaya |
| Apellis Pharmaceuticals, INC. | $29.87 | 2022-2023 | Syfovre |
| Omeros Corporation | $24.88 | 2019 | |
| New World Medical,INC. | $24.84 | 2019-2022 | |
| Thea Pharma INC. | $23.37 | 2023 | Iyuzeh |
| Regeneron Healthcare Solutions, INC. | $18.53 | 2023 | Eylea |
| Genentech USA, INC. | $18.16 | 2022 | |
| Novartis Pharmaceuticals Corporation | $15.54 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $11.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Brame listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.